Bone Density Decline: Tenofovir has become linked to a lower in bone mineral density, escalating the risk of bone challenges or fractures.HIV-1 infected subjects on dolutegravir monotherapy demonstrated speedy and dose-dependent reduction of antiviral action with declines of HIV-one RNA copies for each ml. The antiviral reaction was managed for thr